Discovery Award Winner

About this entry

As an international team of medical doctors, professors, engineers, and material scientists, we are reinventing the way in which antibiotic susceptibility is evaluated, while simultaneously uncovering intricate details of pathogenicity not observed by typical AST. With industry and hospital partnerships, we are currently verifying our low-cost, rapid AST platform with clinical samples using photonic crystal biosensors.  

If you would like to be introduced to this team for collaboration, get in touch with the Longitude prize.